These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

509 related items for PubMed ID: 16492926

  • 1. Joint effects of the CYP1A1 MspI, ERalpha PvuII, and ERalpha XbaI polymorphisms on the risk of breast cancer: results from a population-based case-control study in Shanghai, China.
    Shen Y, Li DK, Wu J, Zhang Z, Gao E.
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):342-7. PubMed ID: 16492926
    [Abstract] [Full Text] [Related]

  • 2. Genetic polymorphisms in the estrogen receptor alpha gene and risk of breast cancer: results from the Shanghai Breast Cancer Study.
    Cai Q, Shu XO, Jin F, Dai Q, Wen W, Cheng JR, Gao YT, Zheng W.
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):853-9. PubMed ID: 14504194
    [Abstract] [Full Text] [Related]

  • 3. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
    Singh V, Rastogi N, Sinha A, Kumar A, Mathur N, Singh MP.
    Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
    [Abstract] [Full Text] [Related]

  • 4. The estrogen receptor alpha gene and breast cancer risk (The Netherlands).
    Onland-Moret NC, van Gils CH, Roest M, Grobbee DE, Peeters PH.
    Cancer Causes Control; 2005 Dec; 16(10):1195-202. PubMed ID: 16215870
    [Abstract] [Full Text] [Related]

  • 5. Polymorphisms in ER-alpha gene interact with estrogen receptor status in breast cancer survival.
    Boyapati SM, Shu XO, Ruan ZX, Cai Q, Smith JR, Wen W, Gao YT, Zheng W.
    Clin Cancer Res; 2005 Feb 01; 11(3):1093-8. PubMed ID: 15709176
    [Abstract] [Full Text] [Related]

  • 6. Polymorphisms in CYP1A1 and breast carcinoma risk in a population-based case-control study of Chinese women.
    Boyapati SM, Shu XO, Gao YT, Cai Q, Jin F, Zheng W.
    Cancer; 2005 Jun 01; 103(11):2228-35. PubMed ID: 15856430
    [Abstract] [Full Text] [Related]

  • 7. Germline genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes in Indian cervical cancer: associations with tumor progression, age and human papillomavirus infection.
    Joseph T, Chacko P, Wesley R, Jayaprakash PG, James FV, Pillai MR.
    Gynecol Oncol; 2006 Jun 01; 101(3):411-7. PubMed ID: 16360200
    [Abstract] [Full Text] [Related]

  • 8. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.
    Chacko P, Joseph T, Mathew BS, Rajan B, Pillai MR.
    Mutat Res; 2005 Mar 07; 581(1-2):153-63. PubMed ID: 15725614
    [Abstract] [Full Text] [Related]

  • 9. [Study on serum organochlorines pesticides (DDTs) level, CYP1A1 genetic polymorphism and risk of breast cancer: a case control study].
    Li JY, Wu DS, Yang F, Zeng HY, Lei FM, Zhou WD, Li H, Tao P.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Mar 07; 27(3):217-22. PubMed ID: 16792888
    [Abstract] [Full Text] [Related]

  • 10. Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study.
    Ishibe N, Hankinson SE, Colditz GA, Spiegelman D, Willett WC, Speizer FE, Kelsey KT, Hunter DJ.
    Cancer Res; 1998 Feb 15; 58(4):667-71. PubMed ID: 9485019
    [Abstract] [Full Text] [Related]

  • 11. Estrogen receptor alpha gene polymorphisms are associated with changes in bone remodeling markers and treatment response to estrogen.
    Rapuri PB, Gallagher JC, Knezetic JA, Haynatzka V.
    Maturitas; 2006 Mar 20; 53(4):371-9. PubMed ID: 16139450
    [Abstract] [Full Text] [Related]

  • 12. Population-based case-control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer risk.
    Long JR, Egan KM, Dunning L, Shu XO, Cai Q, Cai H, Dai Q, Holtzman J, Gao YT, Zheng W.
    Pharmacogenet Genomics; 2006 Apr 20; 16(4):237-43. PubMed ID: 16538170
    [Abstract] [Full Text] [Related]

  • 13. Cytochrome P4501A1 genetic polymorphisms and breast cancer risk in Nigerian women.
    Okobia M, Bunker C, Zmuda J, Kammerer C, Vogel V, Uche E, Anyanwu S, Ezeome E, Ferrell R, Kuller L.
    Breast Cancer Res Treat; 2005 Dec 20; 94(3):285-93. PubMed ID: 16254684
    [Abstract] [Full Text] [Related]

  • 14. [A case control study on the impact of CYP450 MSPI and GST-M1 polymorphisms on the risk of lung cancer].
    Wang BG, Chen SD, Zhou WP, Zeng M, Li ZB, Cai XL, Wang DQ.
    Zhonghua Zhong Liu Za Zhi; 2004 Feb 20; 26(2):93-7. PubMed ID: 15059326
    [Abstract] [Full Text] [Related]

  • 15. Association of breast cancer risk with a GT dinucleotide repeat polymorphism upstream of the estrogen receptor-alpha gene.
    Cai Q, Gao YT, Wen W, Shu XO, Jin F, Smith JR, Zheng W.
    Cancer Res; 2003 Sep 15; 63(18):5727-30. PubMed ID: 14522892
    [Abstract] [Full Text] [Related]

  • 16. Combined effect of menopause age and genotype on occurrence of breast cancer risk in Pakistani population.
    Javed S, Ali M, Sadia S, Aslam MA, Masood AI, Shaikh RS, Sayyed AH.
    Maturitas; 2011 Aug 15; 69(4):377-82. PubMed ID: 21684697
    [Abstract] [Full Text] [Related]

  • 17. Association of p53 polymorphisms with breast cancer: a case-control study in Slovak population.
    Franeková M, Zúbor P, Stanclová A, Dussan CA, Bohusová T, Galo S, Dobrota D, Kajo K, Péc M, Racay P.
    Neoplasma; 2007 Aug 15; 54(2):155-61. PubMed ID: 17319790
    [Abstract] [Full Text] [Related]

  • 18. Joint effect of estrogen receptor beta sequence variants and endogenous estrogen exposure on breast cancer risk in Chinese women.
    Zheng SL, Zheng W, Chang BL, Shu XO, Cai Q, Yu H, Dai Q, Xu J, Gao YT.
    Cancer Res; 2003 Nov 15; 63(22):7624-9. PubMed ID: 14633679
    [Abstract] [Full Text] [Related]

  • 19. Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women.
    Ren Z, Cai Q, Shu XO, Cai H, Li C, Yu H, Gao YT, Zheng W.
    Cancer Epidemiol Biomarkers Prev; 2004 Aug 15; 13(8):1290-5. PubMed ID: 15298948
    [Abstract] [Full Text] [Related]

  • 20. A multigenic study on breast cancer risk associated with genetic polymorphisms of ER Alpha, COMT and CYP19 gene in BRCA1/BRCA2 negative Shanghai women with early onset breast cancer or affected relatives.
    Hu Z, Song CG, Lu JS, Luo JM, Shen ZZ, Huang W, Shao ZM.
    J Cancer Res Clin Oncol; 2007 Dec 15; 133(12):969-78. PubMed ID: 17562079
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.